Selective Digestive Decontamination (SDD) - Selective Orophayngeal Decontamination (SOD) trial

ISRCTN ISRCTN35176830
DOI https://doi.org/10.1186/ISRCTN35176830
Protocol serial number N/A
Sponsor University Medical Centre Utrecht (Netherlands)
Funder Dutch SDD Trialists Group (Netherlands)
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
30/03/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Anne Marie G A de Smet
Scientific

University Medical Center Utrecht, AZU
PO Box 85500
Amsterdam
3508 GA
Netherlands

Phone +31 (0)30 2509111
Email a.desmet@azu.nl

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymSDD-SOD-trial
Study objectivesCan mortality in intensive care unit (ICU) patients be reduced by using SDD or SOD as infection prevention measure, without increasing the development of antibiotic resistance?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedInfection in ICU patients
InterventionSelective Digestive Decontamination.
Selective Oropharyngeal Decontamination.
Intervention typeOther
Primary outcome measure(s)

1. Hospital mortality
2. ICU-mortality

Key secondary outcome measure(s)

1. Prevalence of antibiotic resistance
2. Duration of mechanical ventilation,
3. Duration of ICU-stay,
4. Incidence of hospital infections,
5. Antibiotic use,
6. Health care costs.

Completion date24/07/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexAll
Target sample size at registration3450
Key inclusion criteriaAll patients admitted to the ICU with an expected stay> 72 hours in ICU or with an expected duration of mechanical ventilation > 48 hours
Key exclusion criteria1. Known allergy to study-medication in patient-history
2. Pregnancy
Date of first enrolment01/05/2004
Date of final enrolment24/07/2006

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Center Utrecht, AZU
Amsterdam
3508 GA
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2009 Yes No
Results article survery results 01/01/2010 Yes No
Results article 11 results 01/05/2011 Yes No
Study website Study website 11/11/2025 11/11/2025 No Yes